☰

Patrick M. Schlievert - Publications

Affiliations: 
University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Microbiology
Tree Info Similar researchers PubMed Report error

295 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Leung DYM, Schlievert PM. Kawasaki Syndrome: Role of Superantigens Revisited. The Febs Journal. PMID 32770775 DOI: 10.1111/Febs.15512  0.304
2020 Schlievert PM, Davis CC. Device-Associated Menstrual Toxic Shock Syndrome. Clinical Microbiology Reviews. 33. PMID 32461307 DOI: 10.1128/Cmr.00032-19  0.36
2020 Tiwari N, López-Redondo M, Miguel-Romero L, Kulhankova K, Cahill MP, Tran PM, Kinney KJ, Kilgore SH, Al-Tameemi H, Herfst CA, Tuffs SW, Kirby JR, Boyd JM, McCormick JK, Salgado-Pabón W, ... ... Schlievert PM, et al. The SrrAB two-component system regulates pathogenicity through redox sensitive cysteines. Proceedings of the National Academy of Sciences of the United States of America. PMID 32354997 DOI: 10.1073/Pnas.1921307117  0.346
2020 Jacob HS, Vercellotti GM, Leung DYM, Schlievert PM. Case report of an unusual presentation of Staphylococcus aureus induced toxic shock syndrome/hyperimmunoglobulinemia E syndrome. Medicine. 99: e19746. PMID 32282735 DOI: 10.1097/Md.0000000000019746  0.388
2019 Schlievert PM. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. PMID 31853743 DOI: 10.1007/S10096-019-03685-X  0.316
2019 Fischer AJ, Kilgore SH, Singh SB, Allen PD, Hansen AR, Limoli DH, Schlievert PM. High Prevalence of Enterotoxin Gene Cluster Superantigens in Cystic Fibrosis Clinical Isolates. Genes. 10. PMID 31842331 DOI: 10.3390/Genes10121036  0.317
2019 Schlievert PM, Kilgore SH, Seo KS, Leung DYM. Glycerol Monolaurate Contributes to the Antimicrobial and Anti-inflammatory Activity of Human Milk. Scientific Reports. 9: 14550. PMID 31601928 DOI: 10.1038/S41598-019-51130-Y  0.324
2019 Schlievert PM, Cahill MP, Hostager BS, Brosnahan AJ, Klingelhutz AJ, Gourronc FA, Bishop GA, Leung DYM. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines. Mbio. 10. PMID 30890614 DOI: 10.1128/Mbio.00214-19  0.787
2019 Shannon BA, McCormick JK, Schlievert PM. Toxins and Superantigens of Group A Streptococci. Microbiology Spectrum. 7. PMID 30737912 DOI: 10.1128/Microbiolspec.Gpp3-0054-2018  0.4
2019 Moran M, Brewer M, Schlievert P, Cahill M, Yoshida T, Ward B, Gill S, Beck L. 476 S. aureus virulence factors enhance vaccinia virus infection in human keratinocytes Journal of Investigative Dermatology. 139: S82. DOI: 10.1016/J.Jid.2019.03.552  0.333
2019 Fairley J, Messingham K, Cahill M, Kilgore S, Schlievert P. 094 TSST-1-producing Staphylococcus aureus in bullous pemphigoid Journal of Investigative Dermatology. 139: S16. DOI: 10.1016/J.Jid.2019.03.170  0.372
2018 Peterson M, Kilgore S, Schlievert P. 1362. A Novel Intravesical Antimicrobial for CAUTIs Open Forum Infectious Diseases. 5: S417-S417. DOI: 10.1093/Ofid/Ofy210.1193  0.31
2018 Yoshida T, Grier A, Gill A, Corbett A, Cahill MP, Lockhart A, Simpson EL, Boguniewicz M, Hanifin JM, De Benedetto A, David GL, Leung DY, Schlievert PM, Gill SR, Beck LA. Staphylococcus Aureus -Culture Positivity Observed In Adults With Atopic Dermatitis Is Most Indicative Of An Increased Absolute and Relative Abundance Of S. Aureus and Not Reduced Biodiversity Journal of Allergy and Clinical Immunology. 141: AB129. DOI: 10.1016/J.Jaci.2017.12.413  0.304
2017 Tuffs SW, James DBA, Bestebroer J, Richards AC, Goncheva MI, O'Shea M, Wee BA, Seo KS, Schlievert PM, Lengeling A, van Strijp JA, Torres VJ, Fitzgerald JR. The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function. Plos Pathogens. 13: e1006461. PMID 28880920 DOI: 10.1371/Journal.Ppat.1006461  0.411
2017 Gillman AN, Breshears LM, Kistler CK, Finnegan PM, Torres VJ, Schlievert PM, Peterson ML. Epidermal Growth Factor Receptor Signaling Enhances the Proinflammatory Effects of Staphylococcus aureus Gamma-Toxin on the Mucosa. Toxins. 9. PMID 28657583 DOI: 10.3390/Toxins9070202  0.399
2017 White JR, Gong H, Pope B, Schlievert P, McElroy SJ. Paneth cell disruption-induced necrotizing enterocolitis requires live bacteria and occurs independent of TLR4 signaling. Disease Models & Mechanisms. PMID 28450472 DOI: 10.1242/Dmm.028589  0.32
2017 Herrera A, Kulhankova K, Sonkar VK, Dayal S, Klingelhutz AJ, Salgado-Pabón W, Schlievert PM. Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities. Mbio. 8. PMID 28325766 DOI: 10.1128/Mbio.00273-17  0.366
2016 Breshears LM, Gillman AN, Stach CS, Schlievert PM, Peterson ML. Local Epidermal Growth Factor Receptor Signaling Mediates the Systemic Pathogenic Effects of Staphylococcus aureus Toxic Shock Syndrome. Plos One. 11: e0158969. PMID 27414801 DOI: 10.1371/Journal.Pone.0158969  0.325
2016 Crosby HA, Schlievert PM, Merriman JA, King JM, Salgado-Pabón W, Horswill AR. The Staphylococcus aureus Global Regulator MgrA Modulates Clumping and Virulence by Controlling Surface Protein Expression. Plos Pathogens. 12: e1005604. PMID 27144398 DOI: 10.1371/Journal.Ppat.1005604  0.378
2016 Stach CS, Vu BG, Merriman JA, Herrera A, Cahill MP, Schlievert PM, Salgado-Pabón W. Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis. Plos One. 11: e0154762. PMID 27124393 DOI: 10.1371/Journal.Pone.0154762  0.4
2016 Herrera A, Vu BG, Stach CS, Merriman JA, Horswill AR, Salgado-Pabon W, Schlievert PM. Staphylococcus aureus β-Toxin Mutants Are Defective in Biofilm Ligase and Sphingomyelinase Activity, and Causation of Infective Endocarditis/Sepsis. Biochemistry. PMID 27015018 DOI: 10.1021/Acs.Biochem.6B00083  0.348
2016 Strandberg KL, Rotschafer JH, Schlievert PM. Rabbit Model for Superantigen-Mediated Lethal Pulmonary Disease. Methods in Molecular Biology (Clifton, N.J.). 1396: 81-93. PMID 26676039 DOI: 10.1007/978-1-4939-3344-0_7  0.767
2016 Salgado-Pabón W, Schlievert PM. Aortic Valve Damage for the Study of Left-Sided, Native Valve Infective Endocarditis in Rabbits. Methods in Molecular Biology (Clifton, N.J.). 1396: 73-80. PMID 26676038 DOI: 10.1007/978-1-4939-3344-0_6  0.32
2016 Stach CS, Schlievert PM. Lipopolysaccharide-Induced Toxic Shock Syndrome in Rabbits. Methods in Molecular Biology (Clifton, N.J.). 1396: 67-71. PMID 26676037 DOI: 10.1007/978-1-4939-3344-0_5  0.351
2015 Stach CS, Vu BG, Schlievert PM. Determining the Presence of Superantigens in Coagulase Negative Staphylococci from Humans. Plos One. 10: e0143341. PMID 26599862 DOI: 10.1371/Journal.Pone.0143341  0.352
2015 Mueller EA, Merriman JA, Schlievert PM. Toxic Shock Syndrome Toxin-1, Not Alpha Toxin, Mediated Bundaberg Fatalities. Microbiology (Reading, England). PMID 26432699 DOI: 10.1099/Mic.0.000196  0.398
2015 Merriman JA, Klingelhutz AJ, Diekema DJ, Leung DY, Schlievert PM. Novel Staphylococcus aureus Secreted Protein Alters Keratinocyte Proliferation and Elicits a Proinflammatory Response In Vitro and In Vivo. Biochemistry. 54: 4855-62. PMID 26177220 DOI: 10.1021/Acs.Biochem.5B00523  0.36
2015 Frank KL, Vergidis P, Brinkman CL, Greenwood Quaintance KE, Barnes AM, Mandrekar JN, Schlievert PM, Dunny GM, Patel R. Evaluation of the Enterococcus faecalis Biofilm-Associated Virulence Factors AhrC and Eep in Rat Foreign Body Osteomyelitis and In Vitro Biofilm-Associated Antimicrobial Resistance. Plos One. 10: e0130187. PMID 26076451 DOI: 10.1371/Journal.Pone.0130187  0.379
2015 Haase AT, Rakasz E, Schultz-Darken N, Nephew K, Weisgrau KL, Reilly CS, Li Q, Southern PJ, Rothenberger M, Peterson ML, Schlievert PM. Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge. Plos One. 10: e0129465. PMID 26057743 DOI: 10.1371/Journal.Pone.0129465  0.305
2015 Mueller EA, Schlievert PM. Non-aqueous glycerol monolaurate gel exhibits antibacterial and anti-biofilm activity against Gram-positive and Gram-negative pathogens. Plos One. 10: e0120280. PMID 25799455 DOI: 10.1371/Journal.Pone.0120280  0.376
2015 Vu BG, Stach CS, Kulhankova K, Salgado-Pabón W, Klingelhutz AJ, Schlievert PM. Chronic superantigen exposure induces systemic inflammation, elevated bloodstream endotoxin, and abnormal glucose tolerance in rabbits: possible role in diabetes. Mbio. 6: e02554. PMID 25714716 DOI: 10.1128/Mbio.02554-14  0.374
2014 Frank KL, Colomer-Winter C, Grindle SM, Lemos JA, Schlievert PM, Dunny GM. Transcriptome analysis of Enterococcus faecalis during mammalian infection shows cells undergo adaptation and exist in a stringent response state. Plos One. 9: e115839. PMID 25545155 DOI: 10.1371/Journal.Pone.0115839  0.36
2014 Salgado-Pabón W, Schlievert PM. Models matter: the search for an effective Staphylococcus aureus vaccine. Nature Reviews. Microbiology. 12: 585-91. PMID 24998740 DOI: 10.1038/Nrmicro3308  0.329
2014 Vu BG, Stach CS, Salgado-Pabón W, Diekema DJ, Gardner SE, Schlievert PM. Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. The Journal of Infectious Diseases. 210: 1920-7. PMID 24951827 DOI: 10.1093/Infdis/Jiu350  0.354
2014 van Sorge NM, Cole JN, Kuipers K, Henningham A, Aziz RK, Kasirer-Friede A, Lin L, Berends ET, Davies MR, Dougan G, Zhang F, Dahesh S, Shaw L, Gin J, Cunningham M, ... ... Schlievert PM, et al. The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. Cell Host & Microbe. 15: 729-40. PMID 24922575 DOI: 10.1016/J.Chom.2014.05.009  0.333
2014 Stach CS, Herrera A, Schlievert PM. Staphylococcal superantigens interact with multiple host receptors to cause serious diseases. Immunologic Research. 59: 177-81. PMID 24838262 DOI: 10.1007/S12026-014-8539-7  0.349
2014 Merriman JA, Nemeth KA, Schlievert PM. Novel antimicrobial peptides that inhibit gram positive bacterial exotoxin synthesis. Plos One. 9: e95661. PMID 24748386 DOI: 10.1371/Journal.Pone.0095661  0.344
2014 Salgado-Pabón W, Herrera A, Vu BG, Stach CS, Merriman JA, Spaulding AR, Schlievert PM. Staphylococcus aureus β-toxin production is common in strains with the β-toxin gene inactivated by bacteriophage. The Journal of Infectious Diseases. 210: 784-92. PMID 24620023 DOI: 10.1093/Infdis/Jiu146  0.438
2014 Spaulding AR, Salgado-Pabón W, Merriman JA, Stach CS, Ji Y, Gillman AN, Peterson ML, Schlievert PM. Vaccination against Staphylococcus aureus pneumonia. The Journal of Infectious Diseases. 209: 1955-62. PMID 24357631 DOI: 10.1093/Infdis/Jit823  0.36
2014 Salgado-Pabón W, Case-Cook LC, Schlievert PM. Molecular analysis of staphylococcal superantigens. Methods in Molecular Biology (Clifton, N.J.). 1085: 169-85. PMID 24085696 DOI: 10.1007/978-1-62703-664-1_10  0.301
2013 Walker JN, Crosby HA, Spaulding AR, Salgado-Pabón W, Malone CL, Rosenthal CB, Schlievert PM, Boyd JM, Horswill AR. The Staphylococcus aureus ArlRS two-component system is a novel regulator of agglutination and pathogenesis. Plos Pathogens. 9: e1003819. PMID 24367264 DOI: 10.1371/Journal.Ppat.1003819  0.393
2013 Vu BG, Gourronc FA, Bernlohr DA, Schlievert PM, Klingelhutz AJ. Staphylococcal superantigens stimulate immortalized human adipocytes to produce chemokines. Plos One. 8: e77988. PMID 24205055 DOI: 10.1371/Journal.Pone.0077988  0.314
2013 Salgado-Pabón W, Breshears L, Spaulding AR, Merriman JA, Stach CS, Horswill AR, Peterson ML, Schlievert PM. Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. Mbio. 4. PMID 23963178 DOI: 10.1128/Mbio.00494-13  0.377
2013 Schlievert PM, Merriman JA, Salgado-Pabón W, Mueller EA, Spaulding AR, Vu BG, Chuang-Smith ON, Kohler PL, Kirby JR. Menaquinone analogs inhibit growth of bacterial pathogens. Antimicrobial Agents and Chemotherapy. 57: 5432-7. PMID 23959313 DOI: 10.1128/Aac.01279-13  0.38
2013 Spaulding AR, Salgado-Pabón W, Kohler PL, Horswill AR, Leung DY, Schlievert PM. Staphylococcal and streptococcal superantigen exotoxins. Clinical Microbiology Reviews. 26: 422-47. PMID 23824366 DOI: 10.1128/Cmr.00104-12  0.379
2013 Brosnahan AJ, Merriman JA, Salgado-Pabón W, Ford B, Schlievert PM. Enterococcus faecalis inhibits superantigen toxic shock syndrome toxin-1-induced interleukin-8 from human vaginal epithelial cells through tetramic acids. Plos One. 8: e61255. PMID 23613823 DOI: 10.1371/Journal.Pone.0061255  0.815
2013 Frank KL, Guiton PS, Barnes AM, Manias DA, Chuang-Smith ON, Kohler PL, Spaulding AR, Hultgren SJ, Schlievert PM, Dunny GM. AhrC and Eep are biofilm infection-associated virulence factors in Enterococcus faecalis. Infection and Immunity. 81: 1696-708. PMID 23460519 DOI: 10.1128/Iai.01210-12  0.404
2013 Chen L, Chavda KD, Solanki M, Mediavilla JR, Mathema B, Schlievert PM, Kreiswirth BN. Genetic variation among Panton-Valentine leukocidin-encoding bacteriophages in Staphylococcus aureus clonal complex 30 strains. Journal of Clinical Microbiology. 51: 914-9. PMID 23284024 DOI: 10.1128/Jcm.03015-12  0.348
2013 Al Akhrass F, Abdallah L, Berger S, Hanna R, Reynolds N, Thompson S, Hallit R, Schlievert PM. Streptococcus agalactiae toxic shock-like syndrome: two case reports and review of the literature. Medicine. 92: 10-4. PMID 23263717 DOI: 10.1097/Md.0B013E31827Dea11  0.366
2013 Pereira N, Edlind TD, Schlievert PM, Nyirjesy P. Vaginal toxic shock reaction triggering desquamative inflammatory vaginitis. Journal of Lower Genital Tract Disease. 17: 88-91. PMID 23222054 DOI: 10.1097/Lgt.0B013E3182656991  0.368
2013 Mattis DM, Spaulding AR, Chuang-Smith ON, Sundberg EJ, Schlievert PM, Kranz DM. Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease Protein Engineering, Design and Selection. 26: 133-142. PMID 23161916 DOI: 10.1093/Protein/Gzs094  0.422
2012 Anderson MJ, Lin YC, Gillman AN, Parks PJ, Schlievert PM, Peterson ML. Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Frontiers in Cellular and Infection Microbiology. 2: 64. PMID 22919655 DOI: 10.3389/Fcimb.2012.00064  0.422
2012 Spaulding AR, Satterwhite EA, Lin YC, Chuang-Smith ON, Frank KL, Merriman JA, Schaefers MM, Yarwood JM, Peterson ML, Schlievert PM. Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits. Frontiers in Cellular and Infection Microbiology. 2: 18. PMID 22919610 DOI: 10.3389/Fcimb.2012.00018  0.787
2012 Bin L, Kim BE, Brauweiler A, Goleva E, Streib J, Ji Y, Schlievert PM, Leung DY. Staphylococcus aureus α-toxin modulates skin host response to viral infection. The Journal of Allergy and Clinical Immunology. 130: 683-691.e2. PMID 22840852 DOI: 10.1016/J.Jaci.2012.06.019  0.367
2012 Breshears LM, Schlievert PM, Peterson ML. A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1). The Journal of Biological Chemistry. 287: 32578-87. PMID 22833676 DOI: 10.1074/Jbc.M112.352534  0.357
2012 Kohler PL, Greenwood SD, Nookala S, Kotb M, Kranz DM, Schlievert PM. Staphylococcus aureus isolates encode variant staphylococcal enterotoxin B proteins that are diverse in superantigenicity and lethality. Plos One. 7: e41157. PMID 22815951 DOI: 10.1371/Journal.Pone.0041157  0.395
2012 Schlievert PM, Peterson ML. Glycerol monolaurate antibacterial activity in broth and biofilm cultures. Plos One. 7: e40350. PMID 22808139 DOI: 10.1371/Journal.Pone.0040350  0.371
2012 Spaulding AR, Lin YC, Merriman JA, Brosnahan AJ, Peterson ML, Schlievert PM. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine. 30: 5099-109. PMID 22691432 DOI: 10.1016/J.Vaccine.2012.05.067  0.806
2012 Fan J, Zhang Y, Chuang-Smith ON, Frank KL, Guenther BD, Kern M, Schlievert PM, Herzberg MC. Ecto-5'-nucleotidase: a candidate virulence factor in Streptococcus sanguinis experimental endocarditis. Plos One. 7: e38059. PMID 22685551 DOI: 10.1371/Journal.Pone.0038059  0.367
2012 Schaefers MM, Breshears LM, Anderson MJ, Lin YC, Grill AE, Panyam J, Southern PJ, Schlievert PM, Peterson ML. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1. Plos One. 7: e32813. PMID 22431984 DOI: 10.1371/Journal.Pone.0032813  0.396
2012 Frank KL, Barnes AM, Grindle SM, Manias DA, Schlievert PM, Dunny GM. Use of recombinase-based in vivo expression technology to characterize Enterococcus faecalis gene expression during infection identifies in vivo-expressed antisense RNAs and implicates the protease Eep in pathogenesis. Infection and Immunity. 80: 539-49. PMID 22144481 DOI: 10.1128/Iai.05964-11  0.388
2012 Roggiani M, Schlievert PM. Purification of streptococcal pyrogenic exotoxin a. Methods in Molecular Medicine. 36: 59-66. PMID 21340964 DOI: 10.1385/1-59259-216-3:59  0.368
2011 Wilson GJ, Seo KS, Cartwright RA, Connelley T, Chuang-Smith ON, Merriman JA, Guinane CM, Park JY, Bohach GA, Schlievert PM, Morrison WI, Fitzgerald JR. A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. Plos Pathogens. 7: e1002271. PMID 22022262 DOI: 10.1371/Journal.Ppat.1002271  0.44
2011 Goertz CE, Frasca S, Bohach GA, Cowan DF, Buck JD, French RA, De Guise S, Maratea J, Hinckley L, Ewalt D, Schlievert PM, Karst SM, Deobald CF, St Aubin DJ, Dunn JL. Brucella sp. vertebral osteomyelitis with intercurrent fatal Staphylococcus aureus toxigenic enteritis in a bottlenose dolphin (Tursiops truncatus). Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 23: 845-51. PMID 21908337 DOI: 10.1177/1040638711407683  0.406
2011 DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. Plos One. 6: e22997. PMID 21860665 DOI: 10.1371/Journal.Pone.0022997  0.379
2011 Tyner HL, Schlievert PM, Baddour LM. Beta-hemolytic streptococcal erythroderma syndrome: a clinical and pathogenic analysis. The American Journal of the Medical Sciences. 342: 343-4. PMID 21841465 DOI: 10.1097/Maj.0B013E3182279E6B  0.333
2011 Lin YC, Anderson MJ, Kohler PL, Strandberg KL, Olson ME, Horswill AR, Schlievert PM, Peterson ML. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus. Biochemistry. 50: 7157-67. PMID 21749039 DOI: 10.1021/Bi200435N  0.805
2011 Brosnahan AJ, Schlievert PM. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. The Febs Journal. 278: 4649-67. PMID 21535475 DOI: 10.1111/J.1742-4658.2011.08151.X  0.808
2011 Broccardo CJ, Mahaffey S, Schwarz J, Wruck L, David G, Schlievert PM, Reisdorph NA, Leung DY. Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. The Journal of Allergy and Clinical Immunology. 127: 186-93, 193.e1-11. PMID 21211653 DOI: 10.1016/J.Jaci.2010.10.033  0.326
2011 Malachowa N, Kohler PL, Schlievert PM, Chuang ON, Dunny GM, Kobayashi SD, Miedzobrodzki J, Bohach GA, Seo KS. Characterization of a Staphylococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis. Infection and Immunity. 79: 342-52. PMID 20937760 DOI: 10.1128/Iai.00736-10  0.415
2010 Strandberg KL, Rotschafer JH, Vetter SM, Buonpane RA, Kranz DM, Schlievert PM. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. The Journal of Infectious Diseases. 202: 1690-7. PMID 20979456 DOI: 10.1086/657156  0.782
2010 Schlievert PM, Chuang-Smith ON, Peterson ML, Cook LC, Dunny GM. Enterococcus faecalis endocarditis severity in rabbits is reduced by IgG Fabs interfering with aggregation substance. Plos One. 5. PMID 20957231 DOI: 10.1371/Journal.Pone.0013194  0.333
2010 Wang N, Mattis DM, Sundberg EJ, Schlievert PM, Kranz DM. A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes. Clinical and Vaccine Immunology : Cvi. 17: 1781-9. PMID 20861327 DOI: 10.1128/Cvi.00277-10  0.319
2010 Huseby MJ, Kruse AC, Digre J, Kohler PL, Vocke JA, Mann EE, Bayles KW, Bohach GA, Schlievert PM, Ohlendorf DH, Earhart CA. Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proceedings of the National Academy of Sciences of the United States of America. 107: 14407-12. PMID 20660751 DOI: 10.1073/Pnas.0911032107  0.337
2010 Schlievert PM, Nemeth KA, Davis CC, Peterson ML, Jones BE. Staphylococcus aureus exotoxins are present in vivo in tampons. Clinical and Vaccine Immunology : Cvi. 17: 722-7. PMID 20335433 DOI: 10.1128/Cvi.00483-09  0.349
2010 Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. The Journal of Allergy and Clinical Immunology. 125: 39-49. PMID 20109735 DOI: 10.1016/J.Jaci.2009.10.039  0.788
2010 Strandberg KL, Peterson ML, Lin YC, Pack MC, Chase DJ, Schlievert PM. Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrobial Agents and Chemotherapy. 54: 597-601. PMID 20008774 DOI: 10.1128/Aac.01151-09  0.746
2010 Lin Z, Kotler DP, Schlievert PM, Sordillo EM. Staphylococcal enterocolitis: forgotten but not gone? Digestive Diseases and Sciences. 55: 1200-7. PMID 19609675 DOI: 10.1007/S10620-009-0886-1  0.332
2009 John CC, Niermann M, Sharon B, Peterson ML, Kranz DM, Schlievert PM. Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1893-6. PMID 19911998 DOI: 10.1086/648441  0.365
2009 Strandberg KL, Peterson ML, Schaefers MM, Case LC, Pack MC, Chase DJ, Schlievert PM. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1711-7. PMID 19863450 DOI: 10.1086/644614  0.766
2009 Lin YC, Schlievert PM, Anderson MJ, Fair CL, Schaefers MM, Muthyala R, Peterson ML. Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. Plos One. 4: e7499. PMID 19838303 DOI: 10.1371/Journal.Pone.0007499  0.395
2009 Schlievert PM. Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases. 200: 676-8. PMID 19653828 DOI: 10.1086/605333  0.407
2009 Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, Reilly CS, Peterson ML, Schultz-Darken N, Brunner KG, Nephew KR, Pambuccian S, Lifson JD, Carlis JV, Haase AT. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 458: 1034-8. PMID 19262509 DOI: 10.1038/Nature07831  0.776
2009 Brosnahan AJ, Mantz MJ, Squier CA, Peterson ML, Schlievert PM. Cytolysins augment superantigen penetration of stratified mucosa. Journal of Immunology (Baltimore, Md. : 1950). 182: 2364-73. PMID 19201891 DOI: 10.4049/Jimmunol.0803283  0.799
2009 Assimacopoulos AP, Strandberg KL, Rotschafer JH, Schlievert PM. Extreme pyrexia and rapid death due to Staphylococcus aureus infection: analysis of 2 cases. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 48: 612-4. PMID 19191649 DOI: 10.1086/597009  0.778
2009 Chuang ON, Schlievert PM, Wells CL, Manias DA, Tripp TJ, Dunny GM. Multiple functional domains of Enterococcus faecalis aggregation substance Asc10 contribute to endocarditis virulence. Infection and Immunity. 77: 539-48. PMID 18955479 DOI: 10.1128/Iai.01034-08  0.36
2009 Okere A, Schwartz D, Tierno P, Schlievert P, Hamadeh R. Severe invasive group a streptococcal disease with rhabdomyolysis but without evidence of shock or local myositis Scholarly Research Exchange. DOI: 10.3814/2009/786451  0.382
2008 Brosnahan AJ, Schaefers MM, Amundson WH, Mantz MJ, Squier CA, Peterson ML, Schlievert PM. Novel toxic shock syndrome toxin-1 amino acids required for biological activity. Biochemistry. 47: 12995-3003. PMID 19012411 DOI: 10.1021/Bi801468W  0.8
2008 Schlievert PM, Strandberg KL, Brosnahan AJ, Peterson ML, Pambuccian SE, Nephew KR, Brunner KG, Schultz-Darken NJ, Haase AT. Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrobial Agents and Chemotherapy. 52: 4448-54. PMID 18838587 DOI: 10.1128/Aac.00989-08  0.778
2008 Yang X, Buonpane RA, Moza B, Rahman AK, Wang N, Schlievert PM, McCormick JK, Sundberg EJ, Kranz DM. Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats. The Journal of Infectious Diseases. 198: 344-8. PMID 18522504 DOI: 10.1086/589776  0.337
2008 Weivoda S, Andersen JD, Skogen A, Schlievert PM, Fontana D, Schacker T, Tuite P, Dubinsky JM, Jemmerson R. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand. Journal of Immunological Methods. 336: 22-9. PMID 18436231 DOI: 10.1016/J.Jim.2008.03.004  0.334
2008 Schlievert PM, Case LC, Strandberg KL, Abrams BB, Leung DY. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1562-7. PMID 18419342 DOI: 10.1086/586746  0.782
2008 Squier CA, Mantz MJ, Schlievert PM, Davis CC. Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. Journal of Pharmaceutical Sciences. 97: 9-21. PMID 17721937 DOI: 10.1002/Jps.21077  0.314
2007 Schlievert PM, Case LC. Molecular analysis of staphylococcal superantigens. Methods in Molecular Biology (Clifton, N.J.). 391: 113-26. PMID 18025673 DOI: 10.1007/978-1-59745-468-1_9  0.412
2007 Schlievert PM, Case LC, Nemeth KA, Davis CC, Sun Y, Qin W, Wang F, Brosnahan AJ, Mleziva JA, Peterson ML, Jones BE. Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins. Biochemistry. 46: 14349-58. PMID 18020451 DOI: 10.1021/Bi701202W  0.774
2007 Huseby M, Shi K, Brown CK, Digre J, Mengistu F, Seo KS, Bohach GA, Schlievert PM, Ohlendorf DH, Earhart CA. Structure and biological activities of beta toxin from Staphylococcus aureus. Journal of Bacteriology. 189: 8719-26. PMID 17873030 DOI: 10.1128/Jb.00741-07  0.315
2007 Ulrich M, Bastian M, Cramton SE, Ziegler K, Pragman AA, Bragonzi A, Memmi G, Wolz C, Schlievert PM, Cheung A, Döring G. The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions. Molecular Microbiology. 65: 1276-87. PMID 17697253 DOI: 10.1111/J.1365-2958.2007.05863.X  0.758
2007 Pragman AA, Herron-Olson L, Case LC, Vetter SM, Henke EE, Kapur V, Schlievert PM. Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expression. Journal of Bacteriology. 189: 7515-9. PMID 17693503 DOI: 10.1128/Jb.00547-07  0.786
2007 Schlievert PM. Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci. Antimicrobial Agents and Chemotherapy. 51: 3056-62. PMID 17576832 DOI: 10.1128/Aac.01295-06  0.413
2007 Schlievert PM, Case LC, Strandberg KL, Tripp TJ, Lin YC, Peterson ML. Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005. Journal of Clinical Microbiology. 45: 2704-7. PMID 17537948 DOI: 10.1128/Jcm.02295-06  0.75
2007 Vetter SM, Schlievert PM. The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis. Biochemistry. 46: 7343-52. PMID 17536838 DOI: 10.1021/Bi700184S  0.753
2007 Kotler DP, Sandkovsky U, Schlievert PM, Sordillo EM. Toxic shock-like syndrome associated with staphylococcal enterocolitis in an HIV-infected man. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: e121-3. PMID 17516392 DOI: 10.1086/518286  0.399
2007 Buonpane RA, Churchill HR, Moza B, Sundberg EJ, Peterson ML, Schlievert PM, Kranz DM. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nature Medicine. 13: 725-9. PMID 17515896 DOI: 10.1038/Nm1584  0.373
2007 Brouillard JN, Günther S, Varma AK, Gryski I, Herfst CA, Rahman AK, Leung DY, Schlievert PM, Madrenas J, Sundberg EJ, McCormick JK. Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. Journal of Molecular Biology. 367: 925-34. PMID 17303163 DOI: 10.1016/J.Jmb.2007.01.024  0.314
2007 Pragman AA, Ji Y, Schlievert PM. Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels. Biochemistry. 46: 314-21. PMID 17198402 DOI: 10.1021/Bi0603266  0.724
2007 Ulrich M, Bastian M, Cramton SE, Ziegler K, Pragman AA, Bragonzi A, Memmi G, Wolz C, Schlievert PM, Cheung A, Döring G. The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions Molecular Microbiology. 66: 278-278. DOI: 10.1111/J.1365-2958.2007.05944.X  0.734
2006 Cone LA, Stone RA, Schlievert PM, Sneider RA, Rubin AM, Jesser K, Renker SW. An early favorable outcome of streptococcal toxic shock syndrome may require a combination of antimicrobial and intravenous gamma globulin therapy together with activated protein C. Scandinavian Journal of Infectious Diseases. 38: 960-3. PMID 17148061 DOI: 10.1080/00365540500373224  0.38
2006 Phillips JR, Tripp TJ, Regelmann WE, Schlievert PM, Wangensteen OD. Staphylococcal alpha-toxin causes increased tracheal epithelial permeability. Pediatric Pulmonology. 41: 1146-52. PMID 16998922 DOI: 10.1002/Ppul.20501  0.314
2006 Peterson ML, Schlievert PM. Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry. 45: 2387-97. PMID 16475828 DOI: 10.1021/Bi051992U  0.366
2005 Schlievert PM. Staphylococcal toxic shock syndrome: still a problem. The Medical Journal of Australia. 182: 651-2. PMID 16116687 DOI: 10.5694/J.1326-5377.2005.Tb06859.X  0.301
2005 Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 941-7. PMID 15824983 DOI: 10.1086/428573  0.452
2005 Vetter SM, Schlievert PM. Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis. Antimicrobial Agents and Chemotherapy. 49: 1302-5. PMID 15793101 DOI: 10.1128/Aac.49.4.1302-1305.2005  0.76
2005 Peterson ML, Ault K, Kremer MJ, Klingelhutz AJ, Davis CC, Squier CA, Schlievert PM. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infection and Immunity. 73: 2164-74. PMID 15784559 DOI: 10.1128/Iai.73.4.2164-2174.2005  0.422
2004 Perkins SL, Han DP, Burke JM, Schlievert PM, Wirostko WJ, Tarasewicz DG, Skumatz CM. Intravitreally injected human immunoglobulin attenuates the effects of Staphylococcus aureus culture supernatant in a rabbit model of toxin-mediated endophthalmitis. Archives of Ophthalmology (Chicago, Ill. : 1960). 122: 1499-506. PMID 15477462 DOI: 10.1001/Archopht.122.10.1499  0.33
2004 Kim SW, Grant JE, Kim SI, Swanson TA, Bernstein GA, Jaszcz WB, Williams KA, Schlievert PM. A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 252-60. PMID 15377732 DOI: 10.1176/Jnp.16.3.252  0.33
2004 Pragman AA, Schlievert PM. Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. Fems Immunology and Medical Microbiology. 42: 147-54. PMID 15364098 DOI: 10.1016/J.Femsim.2004.05.005  0.742
2004 Schlievert PM, Tripp TJ, Peterson ML. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. Journal of Clinical Microbiology. 42: 2875-6. PMID 15184497 DOI: 10.1128/Jcm.42.6.2875-2876.2004  0.332
2004 Flood JA, Tripp TJ, Davis CC, Hill DR, Schlievert PM. A toroid model for in vitro investigations of toxic shock syndrome toxin-1 production Journal of Microbiological Methods. 57: 283-288. PMID 15063069 DOI: 10.1016/J.Mimet.2004.01.005  0.374
2004 Pragman AA, Yarwood JM, Tripp TJ, Schlievert PM. Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. Journal of Bacteriology. 186: 2430-8. PMID 15060046 DOI: 10.1128/Jb.186.8.2430-2438.2004  0.798
2003 Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D. A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. American Journal of Rhinology. 17: 321-6. PMID 14750606 DOI: 10.1177/194589240301700601  0.389
2003 Davis CC, Kremer MJ, Schlievert PM, Squier CA. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. American Journal of Obstetrics and Gynecology. 189: 1785-91. PMID 14710116 DOI: 10.1016/S0002-9378(03)00873-1  0.353
2003 Yarwood JM, Schlievert PM. Quorum sensing in Staphylococcus infections. The Journal of Clinical Investigation. 112: 1620-5. PMID 14660735 DOI: 10.1172/Jci20442  0.789
2003 Saiman L, O'Keefe M, Graham PL, Wu F, Saïd-Salim B, Kreiswirth B, LaSala A, Schlievert PM, Della-Latta P. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 37: 1313-9. PMID 14583864 DOI: 10.1086/379022  0.359
2003 Dinges MM, Gregerson DS, Tripp TJ, McCormick JK, Schlievert PM. Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. The Journal of Infectious Diseases. 188: 1142-5. PMID 14551884 DOI: 10.1086/378514  0.714
2003 McCormick JK, Tripp TJ, Llera AS, Sundberg EJ, Dinges MM, Mariuzza RA, Schlievert PM. Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes. Journal of Immunology (Baltimore, Md. : 1950). 171: 1385-92. PMID 12874229 DOI: 10.4049/Jimmunol.171.3.1385  0.685
2003 Travers JB, Leung DY, Johnson C, Schlievert P, Marques M, Cosgrove J, Clay KL. Augmentation of staphylococcal alpha-toxin signaling by the epidermal platelet-activating factor receptor. The Journal of Investigative Dermatology. 120: 789-94. PMID 12713583 DOI: 10.1046/J.1523-1747.2003.12149.X  0.304
2003 Orwin PM, Fitzgerald JR, Leung DY, Gutierrez JA, Bohach GA, Schlievert PM. Characterization of Staphylococcus aureus enterotoxin L. Infection and Immunity. 71: 2916-9. PMID 12704169 DOI: 10.1128/Iai.71.5.2916-2919.2003  0.786
2003 Fitzgerald JR, Reid SD, Ruotsalainen E, Tripp TJ, Liu M, Cole R, Kuusela P, Schlievert PM, Järvinen A, Musser JM. Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infection and Immunity. 71: 2827-38. PMID 12704157 DOI: 10.1128/Iai.71.5.2827-2838.2003  0.35
2003 Holbrook TC, Munday JS, Brown CA, Glover B, Schlievert PM, Sanchez S. Toxic shock syndrome in a horse with Staphylococcus aureus pneumonia. Journal of the American Veterinary Medical Association. 222: 620-3, 601-2. PMID 12619842 DOI: 10.2460/Javma.2003.222.620  0.437
2003 Fey PD, Saïd-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, Kreiswirth BN, Schlievert PM. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 47: 196-203. PMID 12499191 DOI: 10.1128/Aac.47.1.196-203.2003  0.328
2002 Smoot LM, McCormick JK, Smoot JC, Hoe NP, Strickland I, Cole RL, Barbian KD, Earhart CA, Ohlendorf DH, Veasy LG, Hill HR, Leung DY, Schlievert PM, Musser JM. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infection and Immunity. 70: 7095-104. PMID 12438391 DOI: 10.1128/Iai.70.12.7095-7104.2002  0.372
2002 Orwin PM, Leung DY, Tripp TJ, Bohach GA, Earhart CA, Ohlendorf DH, Schlievert PM. Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry. 41: 14033-40. PMID 12437361 DOI: 10.1021/Bi025977Q  0.779
2002 Beres SB, Sylva GL, Barbian KD, Lei B, Hoff JS, Mammarella ND, Liu MY, Smoot JC, Porcella SF, Parkins LD, Campbell DS, Smith TM, McCormick JK, Leung DY, Schlievert PM, et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proceedings of the National Academy of Sciences of the United States of America. 99: 10078-83. PMID 12122206 DOI: 10.1073/Pnas.152298499  0.348
2002 Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, Myones BL, Wheeler JG, Ruthazer R, Schlievert PM. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. The Journal of Pediatrics. 140: 742-6. PMID 12072880 DOI: 10.1067/Mpd.2002.123664  0.333
2002 McCormick JK, Tripp TJ, Dunny GM, Schlievert PM. Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis. The Journal of Infectious Diseases. 185: 994-7. PMID 11920326 DOI: 10.1086/339604  0.346
2002 Yarwood JM, McCormick JK, Paustian ML, Orwin PM, Kapur V, Schlievert PM. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. The Journal of Biological Chemistry. 277: 13138-47. PMID 11821418 DOI: 10.1074/Jbc.M111661200  0.793
2002 Yarwood JM, McCormick JK, Paustian ML, Kapur V, Schlievert PM. Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. Journal of Bacteriology. 184: 1095-101. PMID 11807070 DOI: 10.1128/Jb.184.4.1095-1101.2002  0.786
2002 Hirt H, Schlievert PM, Dunny GM. In vivo induction of virulence and antibiotic resistance transfer in Enterococcus faecalis mediated by the sex pheromone-sensing system of pCF10. Infection and Immunity. 70: 716-23. PMID 11796604 DOI: 10.1128/Iai.70.2.716-723.2002  0.337
2001 Sutkin G, Capelle SD, Schlievert PM, Creinin MD. Toxic shock syndrome after laminaria insertion Obstetrics and Gynecology. 98: 959-961. PMID 11704221 DOI: 10.1016/S0029-7844(01)01502-2  0.366
2001 Dinges MM, Schlievert PM. Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infection and Immunity. 69: 7169-72. PMID 11598096 DOI: 10.1128/Iai.69.11.7169-7172.2001  0.668
2001 Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses Journal of Allergy and Clinical Immunology. 108: S107-S110. PMID 11586276 DOI: 10.1067/Mai.2001.117820  0.407
2001 McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annual Review of Microbiology. 55: 77-104. PMID 11544350 DOI: 10.1146/Annurev.Micro.55.1.77  0.796
2001 McCormick JK, Hirt H, Waters CM, Tripp TJ, Dunny GM, Schlievert PM. Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis. Infection and Immunity. 69: 3305-14. PMID 11292753 DOI: 10.1128/Iai.69.5.3305-3314.2001  0.352
2001 Reed SB, Wesson CA, Liou LE, Trumble WR, Schlievert PM, Bohach GA, Bayles KW. Molecular characterization of a novel Staphylococcus aureus serine protease operon Infection and Immunity. 69: 1521-1527. PMID 11179322 DOI: 10.1128/Iai.69.3.1521-1527.2001  0.37
2001 McCormick JK, Pragman AA, Stolpa JC, Leung DY, Schlievert PM. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infection and Immunity. 69: 1381-8. PMID 11179302 DOI: 10.1128/Iai.69.3.1381-1388.2001  0.74
2001 Dinges MM, Schlievert PM. Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Infection and Immunity. 69: 1256-64. PMID 11179286 DOI: 10.1128/Iai.69.3.1256-1264.2001  0.678
2001 Yarwood JM, McCormick JK, Schlievert PM. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. Journal of Bacteriology. 183: 1113-23. PMID 11157922 DOI: 10.1128/Jb.183.4.1113-1123.2001  0.792
2001 Orwin PM, Leung DY, Donahue HL, Novick RP, Schlievert PM. Biochemical and biological properties of Staphylococcal enterotoxin K. Infection and Immunity. 69: 360-6. PMID 11119525 DOI: 10.1128/Iai.69.1.360-366.2001  0.782
2000 Mitchell DT, Levitt DG, Schlievert PM, Ohlendorf DH. Structural evidence for the evolution of pyrogenic toxin superantigens. Journal of Molecular Evolution. 51: 520-31. PMID 11116326 DOI: 10.1007/S002390010116  0.364
2000 McCormick JK, Hirt H, Dunny GM, Schlievert PM. Pathogenic Mechanisms of Enterococcal Endocarditis. Current Infectious Disease Reports. 2: 315-321. PMID 11095871 DOI: 10.1007/S11908-000-0009-9  0.34
2000 Yarwood JM, Leung DY, Schlievert PM. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. Fems Microbiology Letters. 192: 1-7. PMID 11040420 DOI: 10.1111/J.1574-6968.2000.Tb09350.X  0.773
2000 Roggiani M, Stoehr JA, Olmsted SB, Matsuka YV, Pillai S, Ohlendorf DH, Schlievert PM. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome Infection and Immunity. 68: 5011-5017. PMID 10948118 DOI: 10.1128/Iai.68.9.5011-5017.2000  0.378
2000 McCormick JK, Tripp TJ, Olmsted SB, Matsuka YV, Gahr PJ, Ohlendorf DH, Schlievert PM. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome. Journal of Immunology (Baltimore, Md. : 1950). 165: 2306-12. PMID 10925320 DOI: 10.4049/Jimmunol.165.4.2306  0.323
2000 Schlievert PM, Jablonski LM, Roggiani M, Sadler I, Callantine S, Mitchell DT, Ohlendorf DH, Bohach GA. Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infection and Immunity. 68: 3630-4. PMID 10816521 DOI: 10.1128/Iai.68.6.3630-3634.2000  0.394
2000 Yarwood JM, Schlievert PM. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. Journal of Clinical Microbiology. 38: 1797-803. PMID 10790102 DOI: 10.1128/Jcm.38.5.1797-1803.2000  0.754
2000 Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DYM. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism Journal of Allergy and Clinical Immunology. 105: 820-826. PMID 10756235 DOI: 10.1067/Mai.2000.105524  0.319
2000 Schlievert PM. Will therapeutic peptides be kryptonite for superantigens? Nature Medicine. 6: 378-379. PMID 10742138 DOI: 10.1038/74630  0.325
2000 Rago JV, Vath GM, Bohach GA, Ohlendorf DH, Schlievert PM. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA) Journal of Immunology. 164: 2207-2213. PMID 10657676 DOI: 10.4049/Jimmunol.164.4.2207  0.309
2000 Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clinical Microbiology Reviews. 13: 16-34, table of cont. PMID 10627489 DOI: 10.1128/Cmr.13.1.16-34.2000  0.802
1999 Travers JB, Hamid QA, Norris DA, Kuhn C, Giorno RC, Schlievert PM, Farmer ER, Leung DYM. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis Journal of Clinical Investigation. 104: 1181-1189. PMID 10545517 DOI: 10.1172/Jci6835  0.324
1999 Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by Enterotoxin B-secreting Staphylococcus aureus Clinical Infectious Diseases. 29: 586-589. PMID 10530452 DOI: 10.1086/598638  0.391
1999 Wann ER, Fehringer AP, Ezepchuk YV, Schlievert PM, Bina P, Reiser RF, Höök MM, Leung DYM. Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A Infection and Immunity. 67: 4737-4743. PMID 10456925 DOI: 10.1128/Iai.67.9.4737-4743.1999  0.379
1999 Vath GM, Earhart CA, Monie DD, Iandolo JJ, Schlievert PM, Ohlendorf DH. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity. Biochemistry. 38: 10239-46. PMID 10441117 DOI: 10.1021/Bi990721E  0.742
1999 Hofer MF, Harbeck RJ, Schlievert PM, Leung DYM. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen Journal of Investigative Dermatology. 112: 171-176. PMID 9989792 DOI: 10.1046/J.1523-1747.1999.00492.X  0.35
1998 Cockerill FR, Thompson RL, Musser JM, Schlievert PM, Talbot J, Holley KE, Harmsen WS, Ilstrup DM, Kohner PC, Kim MH, Frankfort B, Manahan JM, Steckelberg JM, Roberson F, Wilson WR. Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 26: 1448-58. PMID 9636878 DOI: 10.1086/516376  0.343
1998 Earhart CA, Mitchell DT, Murray DL, Pinheiro DM, Matsumura M, Schlievert PM, Ohlendorf DH. Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity. Biochemistry. 37: 7194-202. PMID 9585531 DOI: 10.1021/Bi9721896  0.333
1998 Schlievert PM, Gahr PJ, Assimacopoulos AP, Dinges MM, Stoehr JA, Harmala JW, Hirt H, Dunny GM. Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infection and Immunity. 66: 218-23. PMID 9423861 DOI: 10.1128/Iai.66.1.218-223.1998  0.697
1998 Rago JV, Schlievert PM. Scalded skin syndrome Reviews in Medical Microbiology. 9: 9-15. DOI: 10.1097/00013542-199801000-00002  0.346
1997 Rago JV, Schlievert PM. Mechanisms of pathogenesis of staphylococcal and streptococcal superantigens Current Topics in Microbiology and Immunology. 225: 81-97. PMID 9386329 DOI: 10.1007/978-3-642-80451-9_5  0.39
1997 Schlievert PM, Dunny GM, Stoehr JA, Assimacopoulos AP. Aggregation and binding substances enhance pathogenicity in a rabbit model of Enterococcus faecalis endocarditis Advances in Experimental Medicine and Biology. 418: 789-791. PMID 9331770 DOI: 10.1007/978-1-4899-1825-3_186  0.365
1997 Newton D, Norrby-Teglund A, McGeer A, Low DE, Schlievert PM, Kotb M. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates Advances in Experimental Medicine and Biology. 418: 525-529. PMID 9331707 DOI: 10.1007/978-1-4899-1825-3_123  0.389
1997 Holm SE, Köhler W, Kaplan EL, Schlievert PM, Alouf JE, Stevens DL, Kotb M. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. Advances in Experimental Medicine and Biology. 418: 193-9. PMID 9331631 DOI: 10.1007/978-1-4899-1825-3_47  0.344
1997 Assimacopoulos AP, Stoehr JA, Schlievert PM. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome Advances in Experimental Medicine and Biology. 418: 109-114. PMID 9331611 DOI: 10.1007/978-1-4899-1825-3_27  0.387
1997 Leung DYM, Sullivan KE, Brown-Whitehorn TF, Fehringer AP, Allen S, Finkel TH, Washington RL, Makida R, Schlievert PM. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with kawasaki syndrome complicated by coronary artery disease Pediatric Research. 42: 268-272. PMID 9284264 DOI: 10.1203/00006450-199709000-00004  0.345
1997 Roggiani M, Stoehr JA, Leonard BAB, Schlievert PM. Analysis of toxicity of streptococcal pyrogenic exotoxin A mutants Infection and Immunity. 65: 2868-2875. PMID 9199461 DOI: 10.1128/Iai.65.7.2868-2875.1997  0.398
1997 Prasad GS, Radhakrishnan R, Mitchell DT, Earhart CA, Dinges MM, Cook WJ, Schlievert PM, Ohlendorf DH. Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity. Protein Science : a Publication of the Protein Society. 6: 1220-7. PMID 9194182 DOI: 10.1002/Pro.5560060610  0.686
1997 Vath GM, Earhart CA, Rago JV, Kim MH, Bohach GA, Schlievert PM, Ohlendorf DH. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease Biochemistry. 36: 1559-1566. PMID 9048539 DOI: 10.1021/Bi962614F  0.314
1997 Schlievert PM. Searching for superantigens Immunological Investigations. 26: 283-290. PMID 9037631 DOI: 10.3109/08820139709048934  0.351
1996 Wagner JG, Schlievert PM, Assimacopoulos AP, Stoehr JA, Carson PJ, Komadina K. Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: Case report and review Clinical Infectious Diseases. 23: 1159-1161. PMID 8922817 DOI: 10.1093/Clinids/23.5.1159  0.349
1996 Fields BA, Malchiodi EL, Li H, Ysern X, Stauffacher CV, Schlievert PM, Karjalainen K, Mariuzza RA. Crystal structure of a T-cell receptor β-chain complexed with a superantigen Nature. 384: 188-192. PMID 8906797 DOI: 10.1038/384188A0  0.303
1996 Hofer MF, Lester MR, Schlievert PM, Leung DY. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 25: 1218-27. PMID 8821303 DOI: 10.1111/J.1365-2222.1995.Tb03046.X  0.373
1996 Bohach GA, Stauffacher CV, Ohlendorf DH, Chi YI, Vath GM, Schlievert PM. The staphylococcal and streptococcal pyrogenic toxin family Advances in Experimental Medicine and Biology. 391: 131-154. PMID 8726053 DOI: 10.1007/978-1-4613-0361-9_8  0.315
1996 Hofer MF, Newell K, Duke RC, Schlievert PM, Freed JH, Leung DYM. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis Proceedings of the National Academy of Sciences of the United States of America. 93: 5425-5430. PMID 8643591 DOI: 10.1073/Pnas.93.11.5425  0.323
1996 Leung DY, Meissner C, Fulton D, Schlievert PM. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. Journal of Clinical Immunology. 15: 11S-17S. PMID 8613483 DOI: 10.1007/Bf01540888  0.382
1996 Forni AL, Kaplan EL, Schlievert PM, Roberts RB. Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 21: 333-40. PMID 8562741 DOI: 10.1093/Clinids/21.2.333  0.361
1996 Murray DL, Earhart CA, Mitchell DT, Ohlendorf DH, Novick RP, Schlievert PM. Localization of biologically important regions on toxic shock syndrome toxin 1. Infection and Immunity. 64: 371-4. PMID 8557369 DOI: 10.1128/Iai.64.1.371-374.1996  0.352
1996 Schlievert PM. Tampons and toxic shock syndrome Medical Journal of Australia. 164: 635-636. DOI: 10.5694/J.1326-5377.1996.Tb122220.X  0.329
1996 Witcher KJ, Novick RP, Schlievert PM. Modulation of immune cell proliferation by glycerol monolaurate. Clinical and Diagnostic Laboratory Immunology. 3: 10-13. DOI: 10.1128/Cdli.3.1.10-13.1996  0.354
1995 Schlievert PM, Bohach GA, Ohlendorf DH, Stauffacher CV, Leung DY, Murray DL, Prasad GS, Earhart CA, Jablonski LM, Hoffmann ML, Chi YI. Molecular structure of staphylococcus and streptococcus superantigens. Journal of Clinical Immunology. 15: 4S-10S. PMID 8613491 DOI: 10.1007/Bf01540887  0.374
1995 Smith RJ, Schlievert PM, Himelright IM, Baddour LM. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C. Diagnostic Microbiology and Infectious Disease. 19: 245-7. PMID 7851088 DOI: 10.1016/0732-8893(94)90038-8  0.433
1995 Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. The Journal of Experimental Medicine. 181: 747-53. PMID 7836926 DOI: 10.1084/Jem.181.2.747  0.365
1995 Watanabe-Ohnishi R, Low DE, McGeer A, Stevens DL, Schlievert PM, Newton D, Schwartz B, Kreiswirth B, Kotb M. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. The Journal of Infectious Diseases. 171: 74-84. PMID 7798684 DOI: 10.1093/Infdis/171.1.74  0.315
1995 Hussain SM, Luedtke GS, Baker CJ, Schlievert PM, Leggiadro RJ. Invasive group B streptococcal disease in children beyond early infancy. The Pediatric Infectious Disease Journal. 14: 278-81. PMID 7603808 DOI: 10.1097/00006454-199504000-00006  0.328
1995 Leung DY, Meissner HC, Fulton DR, Quimby F, Schlievert PM. Superantigens in Kawasaki syndrome. Clinical Immunology and Immunopathology. 77: 119-26. PMID 7586718 DOI: 10.1006/Clin.1995.1134  0.318
1995 Schlievert PM. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin. The Journal of Infectious Diseases. 172: 1112-4. PMID 7561191 DOI: 10.1093/Infdis/172.4.1112  0.384
1995 Schlievert PM. The role of superantigens in human diseases Current Opinion in Infectious Diseases. 8: 170-174. DOI: 10.1097/00001432-199506000-00005  0.37
1994 Davies HD, Matlow A, Scriver SR, Schlievert P, Lovgren M, Talbot JA, Low DE. Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults Pediatric Infectious Disease Journal. 13: 49-56. PMID 8170732 DOI: 10.1097/00006454-199401000-00011  0.378
1994 Projan SJ, Brown-Skrobot S, Schlievert PM, Vandenesch F, Novick RP. Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. Journal of Bacteriology. 176: 4204-9. PMID 8021206 DOI: 10.1128/Jb.176.14.4204-4209.1994  0.321
1994 Roggiani M, Schlievert PM. Streptococcal toxic shock syndrome, including necrotizing fasciitis and myositis Current Opinion in Infectious Diseases. 7: 423-426. DOI: 10.1097/00001432-199408000-00001  0.346
1993 Leggiadro RJ, Bugnitz MC, Peck BA, Luedtke GS, Kim MH, Kaplan EL, Schlievert PM. Group A streptococcal bacteremia in a mid-south children's hospital. Southern Medical Journal. 86: 615-8. PMID 8506479 DOI: 10.1097/00007611-199306000-00004  0.329
1993 Schlievert PM. Role of superantigens in human disease. The Journal of Infectious Diseases. 167: 997-1002. PMID 8486972 DOI: 10.1093/Infdis/167.5.997  0.424
1993 Schlievert PM, Gocke JE, Deringer JR. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 17: 26-31. PMID 8353243 DOI: 10.1093/Clinids/17.1.26  0.403
1993 Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S, Low DE. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 16: 792-800; discussion . PMID 8329511 DOI: 10.1093/Clind/16.6.792  0.352
1993 Earhart CA, Prasad GS, Murray DL, Novick RP, Schlievert PM, Ohlendorf DH. Growth and analysis of crystal forms of toxic shock syndrome toxin 1. Proteins. 17: 329-34. PMID 8272430 DOI: 10.1002/Prot.340170310  0.307
1993 Prasad GS, Earhart CA, Murray DL, Novick RP, Schlievert PM, Ohlendorf DH. Structure of toxic shock syndrome toxin 1. Biochemistry. 32: 13761-6. PMID 8268150 DOI: 10.1021/Bi00213A001  0.355
1993 Musser JM, Kapur V, Kanjilal S, Shah U, Musher DM, Barg NL, Johnston KH, Schlievert PM, Henrichsen J, Gerlach D. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (Scarlet fever toxin). The Journal of Infectious Diseases. 167: 337-46. PMID 8093623 DOI: 10.1093/Infdis/167.2.337  0.359
1993 Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (London, England). 342: 1385-8. PMID 7901681 DOI: 10.1016/0140-6736(93)92752-F  0.422
1993 Cherchi GB, Kaplan EL, Schlievert PM, Bitti A, Orefici G. First reported case of Streptococcus pyogenes infection with toxic shock-like syndrome in Italy. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 11: 836-8. PMID 1468424 DOI: 10.1007/Bf01960886  0.389
1993 Kotb M, Watanabe-Ohnishi R, Wang B, Tomai MA, Le Gros L, Schlievert PM, El Demellawy M, Geller AM. Analysis of the TCR Vβ Specificities of Bacterial Superantigens Using PCR Immunomethods. 2: 33-40. DOI: 10.1006/Immu.1993.1005  0.366
1992 Lee PK, Schlievert PM. Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus. Current Topics in Microbiology and Immunology. 174: 1-19. PMID 1802616 DOI: 10.1007/978-3-642-50998-8_1  0.303
1992 Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrobial Agents and Chemotherapy. 36: 626-31. PMID 1622174 DOI: 10.1128/Aac.36.3.626  0.391
1992 Chapnick EK, Gradon JD, Lutwick LI, Kim J, Levi M, Kim MH, Schlievert PM. Streptococcal toxic shock syndrome due to noninvasive pharyngitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 14: 1074-7. PMID 1600009 DOI: 10.1093/Clinids/14.5.1074  0.358
1992 Lee PK, Kreiswirth BN, Deringer JR, Projan SJ, Eisner W, Smith BL, Carlson E, Novick RP, Schlievert PM. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated staphylococcus aureus Journal of Infectious Diseases. 165: 1056-1063. PMID 1583323 DOI: 10.1093/Infdis/165.6.1056  0.355
1992 Cone LA, Woodard DR, Byrd RG, Schulz K, Kopp SM, Schlievert PM. A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. The Journal of Infectious Diseases. 165: 638-43. PMID 1552193 DOI: 10.1093/Infdis/165.4.638  0.344
1992 Musser JM, Gray BM, Schlievert PM, Pichichero ME. Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. Journal of Clinical Microbiology. 30: 600-3. PMID 1551976 DOI: 10.1128/Jcm.30.3.600-603.1992  0.361
1992 Begovac J, Gmajnicki B, Schlievert PM, Johnson DR, Kaplan EL. Production of pyrogenic exotoxins in group A streptococci isolated from patients in Zagreb, Croatia. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 11: 540-3. PMID 1526238 DOI: 10.1007/Bf01960810  0.32
1992 Blocki FA, Schlievert PM, Wackett LP. Rat liver protein linking chemical and immunological detoxification systems Nature. 360: 269-270. PMID 1436109 DOI: 10.1038/360269A0  0.332
1992 Cleary PP, Schlievert PM, Handley JP, Kim MH, Hauser AR, Kaplan EL, Wlazlo A. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s The Lancet. 339: 518-521. PMID 1346879 DOI: 10.1016/0140-6736(92)90339-5  0.403
1992 Ostrow RS, Forslund KM, McGlennen RC, Shaw DP, Schlievert PM, Ussery MA, Huggins JW, Faras AJ. Ribavirin mitigates wart growth in rabbits at early stages of infection with cottontail rabbit papillomavirus. Antiviral Research. 17: 99-113. PMID 1313222 DOI: 10.1016/0166-3542(92)90045-7  0.307
1992 Leonard BA, Schlievert PM. Immune cell lethality induced by streptococcal pyrogenic exotoxin A and endotoxin. Infection and Immunity. 60: 3747-3755. DOI: 10.1128/Iai.60.9.3747-3755.1992  0.317
1991 Belani K, Schlievert PM, Kaplan EL, Ferrieri P. Association of exotoxin-producing group A streptococci and severe disease in children. The Pediatric Infectious Disease Journal. 10: 351-4. PMID 2067883 DOI: 10.1097/00006454-199105000-00001  0.348
1991 Lee PK, Deringer JR, Kreiswirth BN, Novick RP, Schlievert PM. Fluid replacement protection of rabbits challenged subcutaneously with toxic shock syndrome toxins Infection and Immunity. 59: 879-884. PMID 1997438 DOI: 10.1128/Iai.59.3.879-884.1991  0.384
1991 Leonard BAB, Lee PK, Jenkins MK, Schlievert PM. Cell and receptor requirements for streptococcal pyrogenic exotoxin T-cell mitogenicity Infection and Immunity. 59: 1210-1214. PMID 1997426 DOI: 10.1128/Iai.59.3.1210-1214.1991  0.332
1991 Valenzuela TD, Hooton TM, Kaplan EL, Schlievert P. Transmission of 'toxic strep' syndrome from an infected child to a firefighter during CPR. Annals of Emergency Medicine. 20: 90-2. PMID 1984738 DOI: 10.1016/S0196-0644(05)81129-1  0.374
1991 Schlievert PM, Kim MH. Reporting of toxic shock syndrome Staphylococcus aureus in 1982 to 1990 [9] Journal of Infectious Diseases. 164: 1245-1246. PMID 1955734 DOI: 10.1093/Infdis/164.6.1245  0.383
1991 Kaplan EL, Johnson DR, Wlazlo A, Kim MH, Schlievert PM. Stability of streptococcal pyrogenic exotoxin production with laboratory manipulation of group A streptococci. The Journal of Infectious Diseases. 164: 1210-1. PMID 1955721 DOI: 10.1093/Infdis/164.6.1210  0.331
1991 Bradley JS, Schlievert PM, Peterson BM. Toxic shock-like syndrome, a complication of strep throat. The Pediatric Infectious Disease Journal. 10: 790. PMID 1945587 DOI: 10.1097/00006454-199110000-00017  0.333
1991 Nelson K, Schlievert PM, Selander RK, Musser JM. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. The Journal of Experimental Medicine. 174: 1271-4. PMID 1940804 DOI: 10.1084/Jem.174.5.1271  0.356
1991 Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome Journal of Clinical Microbiology. 29: 1562-1567. PMID 1684795 DOI: 10.1128/Jcm.29.8.1562-1567.1991  0.397
1991 Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proceedings of the National Academy of Sciences of the United States of America. 88: 2668-72. PMID 1672766 DOI: 10.1073/Pnas.88.7.2668  0.389
1991 Lee PK, Vercellotti GM, Deringer JR, Schlievert PM. Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells Journal of Infectious Diseases. 164: 711-719. PMID 1654356 DOI: 10.1093/Infdis/164.4.711  0.346
1990 McCollister BD, Kreiswirth BN, Novick RP, Schlievert PM. Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: Association with enterotoxin A Infection and Immunity. 58: 2067-2070. PMID 2365451 DOI: 10.1128/Iai.58.7.2067-2070.1990  0.367
1990 Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses Critical Reviews in Microbiology. 17: 251-272. PMID 2206394 DOI: 10.3109/10408419009105728  0.444
1990 Hauser AR, Schlievert PM. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor Journal of Bacteriology. 172: 4536-4542. PMID 2198264 DOI: 10.1128/Jb.172.8.4536-4542.1990  0.31
1990 Musser JM, Schlievert PM, Chow AW, Ewan P, Kreiswirth BN, Rosdahl VT, Naidu AS, Witte W, Selander RK. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proceedings of the National Academy of Sciences of the United States of America. 87: 225-9. PMID 1967495 DOI: 10.1073/Pnas.87.1.225  0.389
1989 Blomster-Hautamaa DA, Schlievert PM. Preparation of toxic shock syndrome toxin-1. Methods in Enzymology. 165: 37-43. PMID 3231114 DOI: 10.1016/S0076-6879(88)65009-9  0.378
1989 Schlievert PM. Immunochemical assays for toxic shock syndrome toxin-1. Methods in Enzymology. 165: 339-44. PMID 3148098 DOI: 10.1016/S0076-6879(88)65050-6  0.401
1989 Rizkallah MF, Tolaymat A, Martinez JS, Schlievert PM, Ayoub EM. Toxic shock syndrome caused by a strain of Staphylococcus aureus that produces enterotoxin C but not toxic shock syndrome toxin-1. American Journal of Diseases of Children (1960). 143: 848-9. PMID 2741860 DOI: 10.1001/Archpedi.1989.02150190098031  0.396
1989 Priest BP, Schlievert PM, Dunn DL. Treatment of toxic shock syndrome with endotoxin-neutralizing antibody. The Journal of Surgical Research. 46: 527-31. PMID 2733415 DOI: 10.1016/0022-4804(89)90014-0  0.331
1989 Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. The New England Journal of Medicine. 321: 1-7. PMID 2659990 DOI: 10.1056/Nejm198907063210101  0.399
1989 Schlievert PM. Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview. Reviews of Infectious Diseases. S107-9. PMID 2648535 DOI: 10.1093/Clinids/11.Supplement_1.S107  0.343
1989 Fast DJ, Schlievert PM, Nelson RD. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production Infection and Immunity. 57: 291-294. PMID 2642470 DOI: 10.1128/Iai.57.1.291-294.1989  0.328
1989 Kreiswirth BN, Projan SJ, Schlievert PM, Novick RP. Toxic Shock Syndrome Toxin 1 is Encoded by A Variable Genetic Element Reviews of Infectious Diseases. 11: S83-S89. PMID 2564693 DOI: 10.1093/Clinids/11.Supplement_1.S83  0.351
1989 Boliach GA, Kreiswirth BN, Novick RP, Schlievert PM. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins b and cl with use of southern hybridization and immunologic assays Reviews of Infectious Diseases. 11: S75-S82. PMID 2494691 DOI: 10.1093/Clinids/11.Supplement_1.S75  0.406
1989 Lee PK, Schlievert PM. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. Journal of Clinical Microbiology. 27: 1890-1892. DOI: 10.1128/Jcm.27.8.1890-1892.1989  0.372
1989 Schlievert PM, Gray ED. Group A streptococcal pyrogenic exotoxin (scarlet fever toxin) type A and blastogen A are the same protein. Infection and Immunity. 57: 1865-1867. DOI: 10.1128/Iai.57.6.1865-1867.1989  0.322
1988 Bohach GA, Hauser AR, Schlievert PM. Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli Infection and Immunity. 56: 1665-1667. PMID 3286506 DOI: 10.1128/Iai.56.6.1665-1667.1988  0.308
1988 Kass EH, Schlievert PM, Parsonnet J, Mills JT. Effect of magnesium on production of toxic-shock-syndrome toxin-1: a collaborative study. The Journal of Infectious Diseases. 158: 44-51. PMID 3134495 DOI: 10.1093/Infdis/158.1.44  0.319
1988 Murphy BG, Kreiswirth BN, Novick RP, Schlievert PM. Localization of a biologically important epitope on toxic-shock-syndrome toxin-1 Journal of Infectious Diseases. 158: 549-555. PMID 2457635 DOI: 10.1093/Infdis/158.3.549  0.341
1988 Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. Journal of Bacteriology. 170: 4365-72. PMID 2457579 DOI: 10.1128/Jb.170.9.4365-4372.1988  0.37
1987 MacDonald KL, Osterholm MT, Hedberg CW, Schrock CG, Peterson GF, Jentzen JM, Leonard SA, Schlievert PM. Toxic shock syndrome: A newly recognized complication of influenza and influenzalike illness Journal of the American Medical Association. 257: 1053-1058. PMID 3806893 DOI: 10.1001/Jama.257.8.1053  0.352
1987 Poindexter NJ, Schlievert PM. Binding of toxic-shock-syndrome toxin-1 to human peripheral blood mononuclear cells. The Journal of Infectious Diseases. 156: 122-9. PMID 3598213 DOI: 10.1093/Infdis/156.1.122  0.332
1987 Bohach GA, Schlievert PM. Expression of staphylococcal enterotoxin C1 in Escherichia coli Infection and Immunity. 55: 428-432. PMID 3542834 DOI: 10.1128/Iai.55.2.428-432.1987  0.326
1987 Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. The New England Journal of Medicine. 317: 146-9. PMID 3299086 DOI: 10.1056/Nejm198707163170305  0.398
1987 Kreiswirth BN, Schlievert PM, Novick RP. Evaluation of coagulase-negative staphylococci for ability to produce toxic shock syndrome toxin 1 Journal of Clinical Microbiology. 25: 2028-2029. PMID 3117846 DOI: 10.1128/Jcm.25.10.2028-2029.1987  0.386
1987 Kreiswirth BN, Handley JP, Schlievert PM, Novick RP. Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis Mgg Molecular &Amp; General Genetics. 208: 84-87. PMID 3112526 DOI: 10.1007/Bf00330426  0.398
1987 Stone RL, Schlievert PM. Evidence for the involvement of endotoxin in toxic shock syndrome. The Journal of Infectious Diseases. 155: 682-9. PMID 2950183 DOI: 10.1093/Infdis/155.4.682  0.38
1986 Blomster-Hautamaa DA, Kreiswirth BN, Novick RP, Schlievert PM. Resolution of highly purified toxic-shock syndrome toxin 1 into two distinct proteins by isoelectric focusing Biochemistry. 25: 54-59. PMID 3954993 DOI: 10.1021/Bi00349A009  0.359
1986 Johnson LP, L'Italien JJ, Schlievert PM. Streptococcal pyrogenic exotoxin type A (scarlet fever toxin) is related to Staphylococcus aureus enterotoxin B Mgg Molecular &Amp; General Genetics. 203: 354-356. PMID 3526093 DOI: 10.1007/Bf00333979  0.313
1986 Poindexter NJ, Schlievert PM. Suppression of immunoglobulin-secreting cells from human peripheral blood by toxic-shock-syndrome toxin-1. The Journal of Infectious Diseases. 153: 772-9. PMID 3512737 DOI: 10.1093/Infdis/153.4.772  0.369
1986 Kreiswirth BN, Kravitz GR, Schlievert PM, Novick RP. Nosocomial transmission of a strain of Staphylococcus aureus causing toxic shock syndrome Annals of Internal Medicine. 105: 704-707. PMID 3021039 DOI: 10.7326/0003-4819-105-5-704  0.388
1986 Johnson LP, Tomai MA, Schlievert PM. Bacteriophage involvement in the group A streptococcal pyrogenic exotoxin A production Journal of Bacteriology. 166: 623-627. PMID 3009415 DOI: 10.1128/Jb.166.2.623-627.1986  0.328
1986 Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Molecular & General Genetics : Mgg. 202: 58-61. PMID 3007938 DOI: 10.1007/Bf00330517  0.358
1986 Schlievert P. Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. The Lancet. 327: 1149-1150. PMID 2871397 DOI: 10.1016/S0140-6736(86)91859-3  0.343
1985 Schlievert PM. Biological properties of toxic shock syndrome exotoxin. Survey and Synthesis of Pathology Research. 3: 54-62. PMID 6505480 DOI: 10.1159/000156915  0.325
1985 Schlievert PM. Effect of magnesium on production of toxic-shock-syndrome toxin-1 by Staphylococcus aureus. The Journal of Infectious Diseases. 152: 618-20. PMID 4031559 DOI: 10.1093/Infdis/152.3.618  0.426
1985 Poindexter NJ, Schlievert PM. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. The Journal of Infectious Diseases. 151: 65-72. PMID 3871225 DOI: 10.1093/Infdis/151.1.65  0.341
1985 Poindexter NJ, Schlievert PM. The Biochemical and Immunological Properties of Toxic-Shock Syndrome Toxin-1 (Tsst-1) and Association with TSS Journal of Toxicology: Toxin Reviews. 4: 1-39. DOI: 10.3109/15569548509014412  0.414
1984 Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production Journal of Infectious Diseases. 149: 471. PMID 6715902 DOI: 10.1093/Infdis/149.3.471  0.421
1984 Johnson LP, Schlievert PM. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A Mgg Molecular &Amp; General Genetics. 194: 52-56. PMID 6374381 DOI: 10.1007/Bf00383496  0.348
1984 Bergdoll M, Schlievert P. Toxic Shock Syndrome Toxin The Lancet. 324: 691. DOI: 10.1016/S0140-6736(84)91241-8  0.347
1983 Pollack M, Weinberg WG, Hoskins WJ, O'Brien WF, Iannini PB, Anderson SE, Schlievert PM. Toxinogenic vaginal infections due to Staphylococcus aureus in menstruating rhesus monkeys without toxic-shock syndrome. The Journal of Infectious Diseases. 147: 963-4. PMID 6842033 DOI: 10.1093/Infdis/147.5.963  0.396
1983 Schlievert PM, Blomster DA. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. The Journal of Infectious Diseases. 147: 236-42. PMID 6827140 DOI: 10.1093/Infdis/147.2.236  0.338
1983 Kreiswirth BN, Löfdahl S, Betley MJ, O'reilly M, Schlievert PM, Bergdoll MS, Novick RP. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage Nature. 305: 709-712. PMID 6226876 DOI: 10.1038/305709A0  0.382
1983 Altemeier WA, Lewis SA, Bjornson HS, Staneck JL, Schlievert PM. Staphylococcus in toxic shock syndrome and other surgical infections. Development of new bacteriophages. Archives of Surgery (Chicago, Ill. : 1960). 118: 281-4. PMID 6218795 DOI: 10.1001/Archsurg.1983.01390030013002  0.402
1983 Bonventre PF, Weckbach L, Staneck J, Schlievert PM, Thompson M. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infection and Immunity. 40: 1023-1029. DOI: 10.1128/Iai.40.3.1023-1029.1983  0.396
1982 Schlievert PM, Kelly JA. Staphylococcal pyrogenic exotoxin type C: Further characterization Annals of Internal Medicine. 96: 982-986. PMID 7091979 DOI: 10.7326/0003-4819-96-6-982  0.411
1982 Schlievert PM, Osterholm MT, Kelly JA, Nishimura RD. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Annals of Internal Medicine. 96: 937-40. PMID 7091971 DOI: 10.7326/0003-4819-96-6-937  0.384
1982 Altemeier WA, Lewis SA, Schlievert PM, Bergdoll MS, Bjornson HS, Staneck JL, Crass BA. Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing. Annals of Internal Medicine. 96: 978-82. PMID 6212008 DOI: 10.7326/0003-4819-96-6-978  0.41
1982 Kreiswirth BN, Novick RP, Schlievert PM, Bergdoll M. Genetic studies on staphylococcal strains from patients with toxic shock syndrome Annals of Internal Medicine. 96: 974-977. PMID 6212007 DOI: 10.7326/0003-4819-96-6-974  0.41
1981 Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. The Journal of Infectious Diseases. 143: 509-16. PMID 6972418 DOI: 10.1093/Infdis/143.4.509  0.425
1981 Schlievert PM. Purification and characterization of staphylococcal pyrogenic exotoxin type B. Biochemistry. 19: 6204-8. PMID 6781533 DOI: 10.1021/Bi00567A040  0.321
1981 Schlievert PM. Staphylococcal scarlet fever: role of pyrogenic exotoxins. Infection and Immunity. 31: 732-736. DOI: 10.1128/Iai.31.2.732-736.1981  0.315
1980 Johnson LP, Schlievert PM, Watson DW. Transfer of group A streptococcal pyrogenic exotoxin production to nontoxigenic strains of lysogenic conversion. Infection and Immunity. 28: 254-7. PMID 6991440 DOI: 10.1128/Iai.28.1.254-257.1980  0.304
1979 Schlievert PM, Schoettle DJ, Watson DW. Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infection and Immunity. 23: 609-17. PMID 457253 DOI: 10.1128/Iai.23.3.609-617.1979  0.409
1979 Schlievert PM, Bettin KM, Watson DW. Production of pyrogenic exotoxin by groups of streptococci: association with group A. The Journal of Infectious Diseases. 140: 676-81. PMID 393776 DOI: 10.1093/Infdis/140.5.676  0.315
1979 Schlievert PM, Schoettle DJ, Watson DW. Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infection and Immunity. 25: 1075-7. PMID 387590 DOI: 10.1128/Iai.25.3.1075-1077.1979  0.308
1979 Schlievert PM, Bettin KM, Watson DW. Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin. Infection and Immunity. 26: 467-72. PMID 161910 DOI: 10.1128/Iai.26.2.467-472.1979  0.311
1979 Schlievert PM, Bettin KM, Watson DW. Natural phosphorylation of group A streptococcal pyrogenic exotoxin type C. Infection and Immunity. 26: 585-9. PMID 121110 DOI: 10.1128/Iai.26.2.585-589.1979  0.303
1978 Barsumian EL, Schlievert PM, Watson DW. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infection and Immunity. 22: 681-8. PMID 365764 DOI: 10.1128/Iai.22.3.681-688.1978  0.316
1978 Schlievert PM, Watson DW. Group A streptococcal pyrogenic exotoxin: pyrogenicity, alteration of blood-brain barrier, and separation of sites for pyrogenicity and enhancement of lethal endotoxin shock. Infection and Immunity. 21: 753-63. PMID 361577 DOI: 10.1128/Iai.21.3.753-763.1978  0.314
1978 Barsumian EL, Cunningham CM, Schlievert PM, Watson DW. Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infection and Immunity. 20: 512-8. PMID 352946 DOI: 10.1128/Iai.20.2.512-518.1978  0.342
1978 Schlievert PM, Bettin KM, Watson DW. Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 157: 472-5. PMID 345284 DOI: 10.3181/00379727-157-40079  0.346
1977 Schlievert PM, Bettin KM, Watson DW. Purification and characterization of group A streptococcal pyrogenic exotoxin type C. Infection and Immunity. 16: 673-9. PMID 324918 DOI: 10.1128/Iai.16.2.673-679.1977  0.323
1974 Larsen B, Schlievert P, Galask R. The spectrum of antibacterial activity of human amniotic fluid determined by scanning electron microscopy American Journal of Obstetrics and Gynecology. 119: 895-903. PMID 4366790 DOI: 10.1016/0002-9378(74)90004-0  0.334
Show low-probability matches.